183 related articles for article (PubMed ID: 31605429)
1. Association of GCK gene DNA methylation with the risk of clopidogrel resistance in acute coronary syndrome patients.
Su J; Zheng N; Li Z; Huangfu N; Mei L; Xu X; Zhang L; Chen X
J Clin Lab Anal; 2020 Feb; 34(2):e23040. PubMed ID: 31605429
[TBL] [Abstract][Full Text] [Related]
2. Association of PON1 gene promoter DNA methylation with the risk of Clopidogrel resistance in patients with coronary artery disease.
Su J; Li J; Yu Q; Xu X; Wang J; Yang J; Li X; Chen X
J Clin Lab Anal; 2019 Jun; 33(5):e22867. PubMed ID: 30891852
[TBL] [Abstract][Full Text] [Related]
3. The DNAm levels of CREB5 (cg11301281) were associated with clopidogrel resistance.
Li J; Yang J; Yu Q; Chen L; Shi X; Su J; Zhu K
J Clin Lab Anal; 2022 Oct; 36(10):e24690. PubMed ID: 36087301
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the GCK gene increase the risk of clopidogrel resistance in stable coronary artery disease (SCAD) patients.
Xu H; Yu Q; Zhou H; Yang J; Zheng N; Xu Z; Su J
Hematology; 2021 Dec; 26(1):447-452. PubMed ID: 34165031
[TBL] [Abstract][Full Text] [Related]
5. Association of P2Y12 gene promoter DNA methylation with the risk of clopidogrel resistance in coronary artery disease patients.
Su J; Li X; Yu Q; Liu Y; Wang Y; Song H; Cui H; Du W; Fei X; Liu J; Lin S; Wang J; Zheng W; Zhong J; Zhang L; Tong M; Xu J; Chen X
Biomed Res Int; 2014; 2014():450814. PubMed ID: 24745016
[TBL] [Abstract][Full Text] [Related]
6. The effect of Xuefu Zhuyu decoction on clopidogrel resistance and its association with the P2Y12 Gene polymorphisms and promoter DNA methylation.
Yu Q; Su J; Zhu K; Yang S; Zhu H; Yu J
Pak J Pharm Sci; 2019 Nov; 32(6):2565-2572. PubMed ID: 31969287
[TBL] [Abstract][Full Text] [Related]
7. [The effects of cytochrome P450 2C19 genetic polymorphism on clopidogrel resistance and recent prognosis of patients with acute coronary syndrome].
Li SN; Liu Z; Luo Y; Chen PA; Lei XM; Li GL
Zhonghua Nei Ke Za Zhi; 2013 Nov; 52(11):961-5. PubMed ID: 24439192
[TBL] [Abstract][Full Text] [Related]
8. The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population.
Su J; Yu Q; Zhu H; Li X; Cui H; Du W; Ji L; Tong M; Zheng Y; Xu H; Zhang J; Zhu Y; Xia Y; Liu T; Yao Q; Yang J; Chen X; Yu J
PLoS One; 2017; 12(3):e0174511. PubMed ID: 28358842
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 CYP 2C19*2 Associated with Adverse 1-Year Cardiovascular Events in Patients with Acute Coronary Syndrome.
Wei YQ; Wang DG; Yang H; Cao H
PLoS One; 2015; 10(7):e0132561. PubMed ID: 26147597
[TBL] [Abstract][Full Text] [Related]
10. Association of CYP2C19 Polymorphism with Clopidogrel Resistance in Patients with Acute Coronary Syndrome in China.
Su Q; Li J; Tang Z; Yang S; Xing G; Liu T; Peng H
Med Sci Monit; 2019 Sep; 25():7138-7148. PubMed ID: 31543510
[TBL] [Abstract][Full Text] [Related]
11. Effects of CYP2C19 allelic variants on inhibition of platelet aggregation and major adverse cardiovascular events in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study.
Ogawa H; Isshiki T; Kimura T; Yokoi H; Nanto S; Takayama M; Kitagawa K; Nishikawa M; Miyazaki S; Ikeda Y; Nakamura M; Tanaka Y; Saito S
J Cardiol; 2016 Jul; 68(1):29-36. PubMed ID: 26521100
[TBL] [Abstract][Full Text] [Related]
12. Genotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel.
Mirzaev KB; Samsonova KI; Potapov PP; Andreev DA; Grishina EA; Ryzhikova KA; Sychev DA
Mol Biol Rep; 2019 Aug; 46(4):4195-4199. PubMed ID: 31102151
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between CYP2C19 Gene Polymorphism with Clopidogrel Resistance and Distribution of Chinese Medicine Syndrome in 229 Acute Coronary Syndrome Patients].
Shen ZJ; Chen XA; Wang YJ; Guo W; Chen TJ; Wang XL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2017 Mar; 37(3):291-296. PubMed ID: 30650477
[TBL] [Abstract][Full Text] [Related]
14. The association of polymorphisms in related circadian rhythm genes and clopidogrel resistance susceptibility.
Su J; Yu Q; Yang J; Zheng N; Zhong J; Ji L; Li J; Chen X
Basic Clin Pharmacol Toxicol; 2021 Sep; 129(3):196-209. PubMed ID: 34117726
[TBL] [Abstract][Full Text] [Related]
15. Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance.
Kim J; Shin BS; Kim DH; Shin DI; Ahn SH; Kim JG; Ryu SH; Moon HR; Kang HG; Jeong H; Yum KS; Chae HY; Kim DH; Kang K; Kim J
BMC Med Genomics; 2024 Jun; 17(1):166. PubMed ID: 38902747
[TBL] [Abstract][Full Text] [Related]
16. The impact of CYP3A5*1/*3, PIA1/A2 and T744C polymorphisms on clopidogrel and acetylsalicylic acid response variability in Mexican population.
Isordia-Salas I; Olalde-Román MJ; Santiago-Germán D; de la Peña NC; Valencia-Sánchez JS
Thromb Res; 2012 Sep; 130(3):e67-72. PubMed ID: 22819265
[TBL] [Abstract][Full Text] [Related]
17. GCK gene-body hypomethylation is associated with the risk of coronary heart disease.
Xu L; Zheng D; Wang L; Jiang D; Liu H; Xu L; Liao Q; Zhang L; Liu P; Shi X; Wang Z; Sun L; Zhou Q; Li N; Huang Y; Le Y; Ye M; Shao G; Duan S
Biomed Res Int; 2014; 2014():151723. PubMed ID: 24696842
[TBL] [Abstract][Full Text] [Related]
18. [Clopidogrel resistance in patients with acute coronary syndrome].
Frolova NS; Shakhnovich RM; Sirotkina OV; Dobrovol'skiĭ AB; Ruda MIa
Ter Arkh; 2010; 82(8):14-20. PubMed ID: 20873239
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of CYP2C19 2 and ABCB1 C3435T affect the pharmacokinetic and pharmacodynamic responses to clopidogrel in 401 patients with acute coronary syndrome.
Wang XQ; Shen CL; Wang BN; Huang XH; Hu ZL; Li J
Gene; 2015 Mar; 558(2):200-7. PubMed ID: 25542807
[TBL] [Abstract][Full Text] [Related]
20. Association between GNAQ Gene DNA Methylation and Vascular Recurrence in Patients with Acute Ischemic Stroke or Transient Ischemic Attack.
Li D; Ling X; Li X; Wei H; Zhao Z; Li X; Ma N
Cerebrovasc Dis; 2022; 51(6):712-721. PubMed ID: 35764070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
